AE11614
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
250mg | 98% | 2 weeks | $451.00 | $316.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AE11614 |
Chemical Name: | Ethyl 1-cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate |
CAS Number: | 103460-87-3 |
Molecular Formula: | C20H23F2N3O3 |
Molecular Weight: | 391.4117 |
MDL Number: | MFCD25973504 |
SMILES: | CCOC(=O)c1cn(C2CC2)c2c(c1=O)cc(c(c2F)N1CCNC(C1)C)F |
The compound Ethyl 1-cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate serves as a valuable building block in chemical synthesis, particularly in the pharmaceutical industry. With its unique structure combining a cyclopropyl ring, difluoro groups, and a piperazine moiety, this compound offers versatility in designing novel molecules with potential biological activity.In chemical synthesis, Ethyl 1-cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate can be used as a key intermediate for the synthesis of various pharmaceutical compounds. Its cyclopropyl group can provide steric hindrance or conformational rigidity, impacting the molecule's interactions with biological targets. The difluoro substituents can enhance the compound's lipophilicity and metabolic stability, while the piperazine moiety can introduce potential for interactions with biological receptors.Overall, the strategic placement of functional groups in Ethyl 1-cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate makes it a valuable precursor for the synthesis of new drug candidates and bioactive compounds with potential therapeutic benefits.